Citation Impact
Citing Papers
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
2003
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease
1999
Inhaled Corticosteroids
2003
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
2002
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
2003
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
1999
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Sildenafil improves hemodynamic parameters in COPD—an investigation of six patients
2005
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Low-dose Almitrine Bismesylate in the Treatment of Hypoxemia due to Chronic Obstructive Pulmonary Disease
1994
Office Spirometry for Lung Health Assessment in Adults
2000
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000
COPD Stage and Risk of Hospitalization for Infectious Disease*
2008
Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
1999
Asthma
2017 Standout
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
2003
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
2007
Chronic Obstructive Pulmonary Disease
2000
Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease
2002
Development and first validation of the COPD Assessment Test
2009 Standout
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
2008
Antibiotic Treatment of Exacerbations of COPD
2007
COPD in Perspective
2002
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
2002
Oxidative stress and redox regulation of lung inflammation in COPD
2006 Standout
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials
2002
The history of COPD
2006
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
2003
The burden of COPD in Italy: results from the confronting COPD survey
2003
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Functional Analysis of the Role of Hypoxia-Inducible Factor 1 in the Pathogenesis of Hypoxic Pulmonary Hypertension
2004 StandoutNobel
Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease
2003
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Additional treatment with clarithromycin reduces fever duration in patients with influenza
2014
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Comparing health inequality in men and women: prospective study of mortality 1986-96
2000
The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD
2003
Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease: A Case for Treatment
2005
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
The socioeconomic status of older adults: How should we measure it in studies of health inequalities?
2001 Standout
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD
2001
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
2003
COPD exacerbations: definitions and classifications
2003
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
2000
Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary Disease
1999
Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation
2001
Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease
1999
The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease
2002
Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
2002
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Lower Respiratory Illnesses Promote FEV 1 Decline in Current Smokers But Not Ex-Smokers with Mild Chronic Obstructive Pulmonary Disease
2001
Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease
2002
Statistical Treatment of Exacerbations in Therapeutic Trials of Chronic Obstructive Pulmonary Disease
2006
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
2004
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
2012
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
2002
Recommendations on the use of exercise testing in clinical practice
2006
Interventions for enhancing medication adherence
2008 Standout
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
2014
Reactive Airways Dysfunction Syndrome (RADS)
1985 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Interventions for enhancing medication adherence
2014 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells
2015 StandoutNobel
Sulphur-dioxide induced bronchial hyperreactivity against acetylcholine
1972
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator
2005
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease
2000
Works of I Bakran being referenced
Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency
1990
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
1998
Untersuchungen zur Ursache der Atemwegsobstruktion und des überempfindlichen Bronchialsystems*
1971